Organization
Intas Pharmaceuticals Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Intas Pharmaceuticals Ltd.
... Eli Lilly and Company (U.S.), Cipla Limited (India), Biocon Limited (India), Intas Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Cadila Pharmaceuticals (India), Lupin Limited ...
... Eli Lilly and Company (U.S.), Cipla Limited (India), Biocon Limited (India), Intas Pharmaceuticals Ltd. (India), Sun Pharmaceutical Industries Ltd. (India), Cadila Pharmaceuticals (India), Lupin Limited ...
... Tibor Hlobik (Marketing Directors, West Pharmaceutical Services), Kirti Maheshwari (Chief Technical Officer, Intas Pharmaceuticals), Matthew Young (Founder and Chief Technology Officer, Oval Medical Technologies), and ...
... Tibor Hlobik (Marketing Directors, West Pharmaceutical Services), Kirti Maheshwari (Chief Technical Officer, Intas Pharmaceuticals), Matthew Young (Founder and Chief Technology Officer, Oval Medical Technologies), and ...
... and Wipro. Vaultize has also won numerous new accounts in India, including Intas Pharmaceuticals, Qatar First Bank, and Yes Bank. Vaultize has captured a growing ...
... facility was primarily supported by a pledge of shares of Accord by Intas Pharmaceuticals, a corporate guarantee by Intas and assignment of shareholder's loan from ...
... Ltd., Hyundai Pharmaceutical Co., Ltd., Impel NeuroPharma, Inc., INSYS Therapeutics, Inc., Intas Pharmaceuticals Ltd., Intra-Cellular Therapies, Inc., INVENT Pharmaceuticals, Inc., Johnson & Johnson, KemPharm, Inc., ...
... would sell Allergan's generics business in the UK and Ireland to India's Intas Pharmaceuticals for �603m. The sale was part of Teva's deal with the ...
... closed earlier in the year. The buyer is Indian pharmaceutical company Intas Pharmaceuticals Ltd., which via its Accord Healthcare subsidiary has agreed to pay 603 ...
... Therapeutics, Inc., Eisai Co., Ltd., Genosco, Hansa Medical AB, Immunomedics, Inc., Intas Pharmaceuticals Ltd., Jiangsu Hengrui Medicine Co., Ltd., Merck & Co., Inc., Momenta Pharmaceuticals, ...
... Emcure Pharmaceuticals, Eurofarma Laboratories, Gedeon Richter, Gilead Sciences, GlaxoSmithKline, Hospira, Impax, InnoPharma, Intas Pharmaceuticals, Jannsen, Lupin, Merck, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Natco Pharma, Nexus ...
... Pharmaceuticals, Inc., InDex Pharmaceuticals AB, Innovate Biopharmaceuticals, Inc., INOXIA Lifesciences GmbH, Intas Pharmaceuticals Ltd., Invion Limited, Johnson & Johnson, Kaken Pharmaceutical Co., Ltd., Kymab Limited, ...
... Qilu Pharmaceutical · 3SBio Chapter 6 profiles leading companies in India: · Intas Biopharmaceuticals. · Reliance Life Sciences · Ranbaxy · Zydus Cadila · Wockhardt ...
... GmbH, Hua Medicine Ltd., Hyundai Pharmaceutical Co., Ltd., INSYS Therapeutics, Inc., Intas Pharmaceuticals Ltd., Intra-Cellular Therapies, Inc., Jiangsu Hansoh Pharmaceutical Co., Ltd., Johnson & Johnson, ...
... offered. Companies profiled this research includes Roche, Tecoland, ScinoPharm, Aarti Group, Cipla, Intas, Hetero, Reliance Group and Guike Pharmaceutical. Order a copy of this 2016 ...
... original investment. In January 2015, Temasek bought some of ChrysCapital's stake in Intas Pharmaceuticals for $144 million. The sale of Mankind Pharma marks the full ...
... original investment. In January 2015, Temasek bought some of ChrysCapital's stake in Intas Pharmaceuticals for $144 million. The sale of Mankind Pharma marks the full ...
... The CEO of Intas Pharmaceuticals expects his company to get FDA approval this year for its ...
... Inc., Johnson & Johnson, Hospira Inc., Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Celltrion, Inc. Key ...
... version of Amgen's Neupogen®. This product has been jointly developed with Intas Pharmaceuticals Ltd. This is the second follow-on biologic FDA submission for Apotex via ...
... Celltrion's Remsima, Hospira's Inflectra and Egis's Flammegis · Epirus Biopharmaceuticals' Infimab · Intas Pharmaceuticals' Mabtas · BIOCAD's AcellBia · Isu Abxis' Clotinab · Reliance Life ...
... Ltd., Hospira Inc., Mylan Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., 3SBio Inc., and ...
... sale exits saw 24 deals worth $280 million. ChrysCap's part exit from Intas Pharma through a sale to Temasek was the most significant secondary deal ...
... Pharma, Inc., Bayer AG, Evofem, Inc., HRA Pharma, Hydra Biosciences, Inc., Intas Pharmaceuticals Ltd., Ligand Pharmaceuticals, Inc., Merck & Co., Inc., Orbis Biosciences, Inc., Pantarhei ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤